Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

References

• Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, . Peritoneal carcinomatosis from non- gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358–63.
   PubMed Web of Science ®Google Scholar
• Meijer S, De Bakker OJ, Hoitsma HF. Palliative resection in gastric cancer. J Surg Oncol 1983;23:77–80.
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Yu W, Baratti D, Kusamura S, Deraco M. Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 2008;98:273–6.
   PubMed Web of Science ®Google Scholar
• Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006;24:2903–9.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, . Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997;8:163–8.
   PubMed Web of Science ®Google Scholar
• Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg Acta Chir 2002;168:597–608.
   PubMedGoogle Scholar
• Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, . Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004;139:20–6.
   PubMed Web of Science ®Google Scholar
• Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R, . Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454–63.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005;92:370–5.
   PubMed Web of Science ®Google Scholar
• Baratti D, Scivales A, Balestra MR, Ponzi P, Di Stasi F, Kusamura S, . Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 2010;36:463–9.
   PubMed Web of Science ®Google Scholar
• Spiliotis J, Tentes AA, Vaxevanidou A, Korakianitis OS, Rogdakis A, Mirelis C, G, . Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece. J Buon 2008;13:205–10.
   PubMed Web of Science ®Google Scholar
• Bonastre J, Jan P, de Pouvourville G, Pocard M, Estphan G, Elias D. [Cost of an intraperitoneal chemohyperthermia (IPCH) related to cytoreductive surgery]. Ann Chir 2005; 130:553–61.
   PubMedGoogle Scholar
• Bonastre J, Chevalier J, Elias D, Classe JM, Ferron G, Guilloit JM, . Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer. Value Health 2008;11: 347–53.
   PubMed Web of Science ®Google Scholar
• Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, . Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg 2010;251:323–9.
   PubMed Web of Science ®Google Scholar
• DTCD ND. Common terminology criteria for adverse events v3.0 (CTAE). In: Cancer Therapy Evaluation Program; 2006
   Google Scholar
• Glimelius B, Sorbye H, Balteskard L, Bystrom P, Pfeiffer P, Tveit K, . A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer. Ann Oncol 2008;19:909–14.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29–42.
   PubMed Web of Science ®Google Scholar
• Vazquez Vde L, Sugarbaker PH. Cholecystectomy, lesser omentectomy, and stripping of the omental bursa: A peritonectomy procedure. J Surg Oncol 2003;84:45–9.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–31.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Averbach AM, Jacquet P, Stephens AD, Stuart OA. A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor. Cancer Treat Res 1996;82:415–21.
   PubMedGoogle Scholar
• Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, . Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: Pharmacokinetics and tissue distribution. Ann Oncol 2002; 13:267–72.
   PubMed Web of Science ®Google Scholar
• Gubanski M, Johnsson A, Fernebro E, Kadar L, Karlberg I, Flygare P, . Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: The GATAC trial. Gastric Cancer 2010;13:155–61.
   PubMed Web of Science ®Google Scholar
• OANDA [Internet]. OANDA Foreign Exchange Information. 2009. Available from: http://wwwoanda.com.
   Google Scholar
• Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996;32A:1135–41.
   PubMed Web of Science ®Google Scholar
• Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587–91.
   PubMed Web of Science ®Google Scholar
• Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993;72:37–41.
   PubMed Web of Science ®Google Scholar
• Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, . Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New Engl J Med 2001;345:725–30.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, . Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737–43.
   PubMed Web of Science ®Google Scholar
• Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health 2004;7: 518–28.
   PubMed Web of Science ®Google Scholar
• van Leeuwen BL, Graf W, Pahlman L, Mahteme H. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 2008;15: 745–53.
   PubMed Web of Science ®Google Scholar
• Hansson J, Graf W, Pahlman L, Nygren P, Mahteme H. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2009;35:202–8.
   PubMed Web of Science ®Google Scholar